Device Orthodontics

Miniendo II

Payments companies reported to CMS as associated with Miniendo II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$9,409associated payments (2023-2025)
252clinicians with associated payments
2companies reporting

By year

2023 $3,102
2024 $2,821
2025 $3,487

Payments reported as associated with Miniendo II, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $7,295
Dentist $1,138
General Practice (Dentist) $619
Emergency Medicine $64.77
Oral and Maxillofacial Surgery $45.50
Pediatric Dentistry $45.50

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Miniendo II

These are the largest totals companies reported as associated with Miniendo II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Christopher Massey Lubbock, TX Orthodontics and Dentofacial Orthopedics $232.90
Scott Morita Aiea, HI Orthodontics and Dentofacial Orthopedics $193.77
Brian Dugoni Fort Worth, TX Orthodontics and Dentofacial Orthopedics $146.12
Saam Zarrabi Fort Worth, TX General Practice (Dentist) $146.12
Brooke Skolnick Roseland, NJ Dentist $143.69
Lawrence Moranda Palm Desert, CA Orthodontics and Dentofacial Orthopedics $141.14
John Mcgrory Lake Jackson, TX Orthodontics and Dentofacial Orthopedics $140.75
James St Clair Lubbock, TX Orthodontics and Dentofacial Orthopedics $131.30
Kelly Klontz Oklahoma City, OK Orthodontics and Dentofacial Orthopedics $130.89
Lubna Khan Trumbull, CT Orthodontics and Dentofacial Orthopedics $116.72

Prescribed Miniendo II?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.